INAR Stock | News | Quote | Stock Forum |

New Post Public Reply Private Reply Replies (0) Message Board
Rosner
$INAR InternetArray, Inc. INAR Company Overview 

InternetArray, Inc. INAR Current Price and Quotes
Last Price 0.0004
Previous Close 0.0005 Open 0.0006
Daily Range 0.0006 - 0.0004 52wk Range 0.0006 - 0.0001
Volume 199,919,688 Dividend N/A
Average Vol (3m) 114,499,168 Yield N/A

INAR Stock Message Board http://investorshangout.com/search?q=INAR&...mp;yt1=Go!

Last Updated:

InternetArray, Inc. INAR
Company Information

7954 Transit Road
#232
Williamsville, NY 14221-4117

Website: http://www.internetarray.com
Phone: 917-387-4410
Email: contact@internetarray.com

InternetArray, Inc. INAR
Internet applications and services.

InternetArray, Inc. INAR
Financial Reportings and Disclosures

Reporting Status Dark: Alternative Reporting Standard
Deregistered a/o Mar 15, 2007
Audited Financials Unaudited
Latest Report Sep 30, 2012 Quarterly Report
CIK 0001095963
Fiscal Year End 12/31
OTC Marketplace OTC Pink No Information
Profile Data

SIC - Industry Classification 9999 - Nonclassifiable establishments
Business Status Development Stage Company a/o Oct 02, 2008
Incorporated In: DE, USA
Year of Inc. 2008
Employees 0 a/o Oct 02, 2008
Company Officers/Contacts

Michael Black President
Company Directors

Michael Black
Company Notes

Formerly=U.S. MedSys Corp. until 9-2008
Formerly=Prime Rate Income & Dividend Enterprises, Inc. until 3-04
Service Providers

Auditor/Accountant
Not Available
Legal Counsel
William Haseltine, Esq
1629 K St NW,
Washington, DC, 20006
United States

Meritz & Muenz LLP
2021 O Street, NW
Washington, DC, 20036
United States

Investor Relations Firm
Not Available

InternetArray, Inc. INAR
INAR Security Details

Share Structure

Market Value1 $1,367,308 a/o Feb 13, 2014
Shares Outstanding 3,418,271,060 a/o Sep 30, 2012
Float 167,638,032 a/o Dec 31, 2011
Authorized Shares 19,900,000,000 a/o Jun 30, 2012
Par Value  No Par Value
Shareholders

Shareholders of Record 1,069 a/o Dec 31, 2011
Security Notes

Capital Change=shs decreased by 1 for 1000 split Pay date=01/16/2009.
Capital Change=shs decreased by 1 for 2500 split. Pay date=03/14/2011.
Short Selling Data

Short Interest 0 (-100%)
Sep 13, 2013
Significant Failures to Deliver  No
Transfer Agent(s)

Corporate Stock Transfer, Inc.

InternetArray, Inc. INAR Financials
INAR


InternetArray, Inc. INAR Recent News

INAR InternetArray, Inc. Research DD Guide

Stock Message Board http://investorshangout.com/search?q=INAR&...mp;yt0=Go!
Stock Quote http://www.otcmarkets.com/stock/INAR/quote
Stock Chart http://www.otcmarkets.com/stock/INAR/chart
Company Info http://www.otcmarkets.com/stock/INAR/company-info
Recent News http://www.otcmarkets.com/stock/INAR/news
Financials http://www.otcmarkets.com/stock/INAR/financials
Filings and Disclosure http://www.otcmarkets.com/stock/INAR/filings
Short Sales http://www.otcmarkets.com/stock/INAR/short-sales
Insider Disclosure http://www.otcmarkets.com/stock/INAR/insider-transactions
Research Reports http://www.otcmarkets.com/stock/INAR/research
Summary http://finance.yahoo.com/q?s=INAR
Historical Prices http://finance.yahoo.com/q/hp?s=INAR+Historical+Prices
Interactive Chart http://finance.yahoo.com/echarts?s=INAR
Basic Chart http://finance.yahoo.com/q/bc?s=INAR+Basic+Chart
Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=INAR+Basic+Tech.+Analysis
Headlines http://finance.yahoo.com/q/h?s=INAR+Headlines
Press Releases http://finance.yahoo.com/q/p?s=INAR+Press+Releases
Company Profile http://finance.yahoo.com/q/pr?s=INAR+Profile
Key Statistics http://finance.yahoo.com/q/ks?s=INAR+Key+Statistics
Industry http://finance.yahoo.com/q/in?s=INAR+Industry
Major Holders http://finance.yahoo.com/q/mh?s=INAR+Major+Holders
Insider Transactions http://finance.yahoo.com/q/it?s=INAR+Insider+Transactions
Insider Roster http://finance.yahoo.com/q/ir?s=INAR+Insider+Roster
Income Statement http://finance.yahoo.com/q/is?s=INAR
Balance Sheet http://finance.yahoo.com/q/bs?s=INAR
Cash Flow http://finance.yahoo.com/q/cf?s=INAR+Cash+Flow&annual
Nasdaq http://www.nasdaq.com/symbol/INAR
Market Watch http://www.marketwatch.com/investing/stock/INAR
Bloomberg http://www.bloomberg.com/quote/INAR:US
Morningstar http://quotes.morningstar.com/stock/s?t=INAR
Bussinessweek http://investing.businessweek.com/research/st...icker=INAR
Barchart http://www.barchart.com/quotes/stocks/INAR
OTC Short Report http://otcshortreport.com/index.php?index=INAR
Investopedia http://www.investopedia.com/markets/stocks/INAR/?wa=0

List of all stock message boards and tickers for OTC BB Pinks & Penny Stocks http://investorshangout.com/board?categoryid=OTC
Scroll down for more posts ▼

Top 10 Most Recent News Articles

LG's ASIL D Certification: A Game Changer in Autos

Updated Category News Views 170

Why LG's ASIL D Certification Matters There ain't much in the tangled mess of automotive innovations these days that'll make a seasoned investor raise an eyebrow, but here comes LG Electronics grabbing the ASIL D certification like it's a badge of market honor. The ISO 26262 ASIL D is no walk in the park, folks—it's the top rung on the safety ladder, something that's...

Continue Reading
Gildan's Crisis: Investors Face Losses Amid Lawsuit

Updated Category News Views 245

Gildan Investors, Brace Yourself Poor old Gildan Activewear finds itself in hot water again, with a class action lawsuit cropping up like an unexpected storm on farmers' day. Any traders remotely involved with NYSE:GIL should pay damn close attention, because with a December 14, 2026 deadline looming, it's crunch time. The Root of the Lawsuit The plot thickens here,...

Continue Reading
GlycoNex Eyes Japanese Market with Denosumab Biosimilar

Updated Category News Views 108

A Strategic Step into the Japanese Market Alright folks, there's a new kid aiming to shake things up in the biotech neighborhood, and it's GlycoNex with its denosumab biosimilar, SPD8. These guys just tossed their hat in the ring with a regulatory submission to Japan's Pharmaceuticals and Medical Devices Agency (PMDA). If the cosmic forces align, they might snag an...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 358

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 336

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 364

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
Fibocom LTE Modules Test Drive Satellite Connectivity

Updated Category News Views 153

Boosting IoT with Satellite Connectivity Here's a good one for folks watching the edge of wireless innovation. Fibocom's LTE Cat.1 bis modules, the LE270-EU and LE271-GL, just stretched their legs in New Zealand, connecting seamlessly with SpaceX's Direct to Cell (DTC) satellite system. No fancy hardware swaps, just standard firmware strutting its stuff across satellite...

Continue Reading
Antengene’s AnTenGager-D2 Advances in Cancer Treatment

Updated Category News Views 86

Antengene's AnTenGager-D2 Offers Fresh Hope Alright, let's dig into the latest buzz from the 2026 Society for Immunotherapy of Cancer conference about Antengene's AnTenGager-D2 platform. If you're not into biotech lingo, buckle up, because this is a ride into the future of cancer treatments—where science fiction might soon become science fact. A Novel Approach to Tumor...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 372

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
Cultural Tech Fusion: The Asia-Pacific Way Forward

Updated Category News Views 64

A High-Tech Twist on Traditional Culture You ever walk into a room and see a robot perform kung fu? I'll admit, it caught me off guard at first. But that's exactly what happened at the "Enduring Heritage, Harmonious Asia-Pacific" special exhibition in Shenzhen. With all the usual high-ranking execs and cultural bigwigs there, nobody expected a showcase where Wing Chun...

Continue Reading

Top 5 Most Recently Viewed Articles

Analyzing Trump's Executive Orders and Their Economic Impact

Updated Category News Views 806

Executive Orders: A Shift in Economic Paradigms President Trump has taken significant steps by issuing a number of executive orders that have raised eyebrows among economists and market analysts alike. According to market expert Louis Navellier, this approach can be characterized as 'shock and awe'. It reflects a bold strategy that could reshape various aspects of the...

Continue Reading
B2PRIME Expands Institutional Reach with Stuart Brock's Addition

Updated Category News Views 173

B2PRIME Welcomes Stuart Brock as Institutional Business Development Manager B2PRIME Group, a leading financial services provider for institutional and professional clients, recently announced the appointment of Stuart Brock as its Institutional Business Development Manager. With over 15 years of experience in electronic trading and institutional sales, Stuart is poised to...

Continue Reading
United Parks & Resorts Inc. Shares Q1 2025 Financial Insights

Updated Category News Views 374

Financial Overview of United Parks & Resorts Inc. United Parks & Resorts Inc. (NYSE: PRKS), a prominent player in the theme park and entertainment sector, has recently shared its financial results for the first quarter of 2025. This report delves into the key metrics and operational insights that define the company’s performance in this period. Attendance and Revenue...

Continue Reading
Seongnam Pavilion Sets New Benchmark at CES 2025 with 41 Companies

Updated Category News Views 178

Seongnam Pavilion Makes Waves at CES 2025 At the latest CES 2025, Seongnam City showcased an impressive turnout at the world's leading consumer electronics exhibition. This year, Seongnam participated with a remarkable delegation of 41 companies, marking the largest participation ever. Focused on enhancing their global footprint, these small and medium-sized enterprises...

Continue Reading
Gaucho Holdings Seizes Opportunities Amid Argentina's Economic Revival

Updated Category News Views 179

Gaucho Holdings and the New Economic Landscape in Argentina Recently, Argentina has entered a new chapter of economic transformation. A shift in leadership, with Javier Milei becoming president, has sparked hopes for fiscal discipline, growth, and development. As the country embraces pro-market reforms, Gaucho Group Holdings, Inc. (NASDAQ: VINO) positions itself to...

Continue Reading